23 Nov

Change of Directors Interest Notice - Tony Charara

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Tissue Repair Ltd ABN 20 158 411 566 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Tony Charara Date of last notice 22 November 2021 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct interest Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. N/A Date of change 19 November 2021 and 22 November 2021 Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 No. of securities held prior to change Spark Ca pital Pty Limited • 4,656,83 0 Fully Paid Ordinary Shares (escrowed until 15 November 2023) • 165,430 Fully Paid Ordinary Shares (escrowed voluntarily until 16 May 2024) • 9,540,000 Options exercisable at $0.205 5 expiring 30/12/33 (escrowed voluntarily until 16 May 2024) • 2,500,000 Optio ns exercisable at $0.3715 expiring 30/08/34 (escrowed voluntarily until 16 May 2024) • 1,600,000 Options exercisable at $1.15 expiring 15/11/36 (escrowed voluntarily until 16 May 2024) Class Fully Paid Ordinary Shares Number acquired 73,076 Fully Paid Ordinary Shares Number disposed Nil Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation $ 49,364.53 Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3 No. of securities held after change Spark Capital Pty Limited • 4,656,83 0 Fully Paid Ordinary Shares (escr owed until 15 November 2023) • 165,430 Fully Paid Ordinary Shares (escrowed voluntarily until 16 May 2024) • 9,540,000 Options exercisable at $0.205 5 expiring 30/12/33 (escrowed voluntarily until 16 May 2024) • 2,500,000 Optio ns exercisable at $0.3715 expiring 30/08/34 (escrowed voluntarily until 16 May 2024) • 1,600,000 Options exercisable at $1.15 expiring 15/11/36 (escrowed voluntarily until 16 May 2024) Tony Charara • 73,076 Fully Paid Ordinary Shares Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back On - market trade on 19 November 2021 and 22 November 2021 Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities t o which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A Interest acquired N/A Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 4 01/01/2011 Interest disposed N/A Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation N/A Interest after change N/A Part 3 – + Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? N o If so, was prior written clearance provi ded to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A

More from Tissue Repair Ltd


Join Listcorp to create a personalised news feed, follow your favourite companies, save useful news, and more.

By joining Listcorp you agree to our Terms & Conditions and Privacy Policy

Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Tissue Repair Ltd (ASX:TRP) when you join Listcorp.